COMP <GO>
USPH vs UNH // GROSS PROFIT MARGIN
U.S. Physical Therapy Inc. (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: USPH 6
— UNH 7
▲ GROSS PROFIT MARGIN LEADER: UNH
LAST: $86.57 (+1.47%) • MKT CAP: $1.29B
gross-margins
19.20%
LAST: $410.91 (+0.94%) • MKT CAP: $368.83B
gross-margins
88.57%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (USPH VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | USPH | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 19.20% | 88.57% | -69.37 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.50% | 11.47% | +0.03 | USPH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 16.3x | 16.4x | -0.15 | USPH | /valuation <GO> |
| Free Cash Flow Yield | 5.81% | 6.48% | -0.67 | UNH | /fcf-yield <GO> |
| Operating Margin | 11.10% | 4.82% | +6.28 | USPH | /operating-margins <GO> |
| Net Profit Margin | 5.10% | 3.14% | +1.96 | USPH | /net-margins <GO> |
| Revenue Growth (YoY) | 16.30% | 6.46% | +9.84 | USPH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.12% | 2.28% | -0.16 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.94 | 3.12 | -0.18 | UNH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | USPH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.74% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 52.3 | 59.2 | -6.95 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 27.4x | 17.1x | +10.31 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.29B | $368.83B | -$367.54B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | USPH REV | UNH REV | USPH GROSS % | UNH GROSS % | USPH FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $781.0M | $447.57B | 19.2% | 88.7% | $75.1M | $16.07B |
| FY 2024 | $671.3M | $400.28B | 18.5% | 88.3% | $74.9M | $20.70B |
| FY 2023 | $604.8M | $371.62B | — | 89.6% | $82.0M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
USPH // BETA —
UNH // BETA 0.33